Weak signal
Confirm antigen integrity, epitope access, antibody orientation, detector activity, incubation time, and standard preparation. More antibody can increase background without improving the useful signal window.
Optimization becomes inefficient when every reagent is changed at once. First classify the dominant failure—weak signal, high background, matrix interference, poor precision, or an unstable calibration curve—then test the smallest set of variables that can explain it.

Confirm antigen integrity, epitope access, antibody orientation, detector activity, incubation time, and standard preparation. More antibody can increase background without improving the useful signal window.
Review nonspecific binding, blocking chemistry, wash performance, detector concentration, plate choice, sample matrix, and edge effects. Compare blank, zero standard, and negative matrix separately.
Distinguish pipetting and plate-handling variability from reagent instability or matrix heterogeneity. Replicate CV must be reviewed across standards, controls, and samples—not only the calibration curve.
A high curve-fit statistic does not demonstrate that controls recovered correctly, replicates were precise, samples were inside the reportable range, or dilutional behavior was acceptable.
| Stage | Question | Typical output |
|---|---|---|
| Reagent feasibility | Can the pair produce a specific signal window? | Candidate pair and basic format. |
| Condition optimization | Which concentrations, buffers, times, and washes improve discrimination? | Draft plate method. |
| Matrix evaluation | Does the real sample behave like the calibrator system? | Dilution and matrix strategy. |
| Performance confirmation | Is the assay sufficiently precise, sensitive, and reproducible for its purpose? | Fit-for-purpose evidence and limitations. |
Send the target, sample matrix, available antibodies or kit, expected range, and current failure pattern. VexisBio can scope focused troubleshooting or staged custom development.
Custom ELISA Development